NCT03931486

Brief Summary

The etiology and pathogenesis of acute Achilles tendon ruptures are complex and not fully understood. It is well known that they are associated with pre-existing pathological alterations, similar to the changes observed in tendinopathy. The present study investigates if bacteria and collagen metabolism play a role in the etiology of acute Achilles tendon rupture. During surgery, 20 patients will have taken two biopsies from the ruptured part of the tendon and two biopsies from the healthy tissue of the same tendon 2-4 cm proximal to the rupture, as a control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 30, 2019

Completed
3 days until next milestone

Study Start

First participant enrolled

May 3, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

July 29, 2021

Status Verified

July 1, 2021

Enrollment Period

1.9 years

First QC Date

April 15, 2019

Last Update Submit

July 28, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • 14C concentration in acutely ruptured Achilles tendons

    14C concentration in biopsies from the ruptured part of the tendons and in the control biopsies proximal to the rupture are compared to the known historical values of atmospheric 14C to estimate the rate of collagen turnover. The values for turnover in the biopsies will be compared to the known rates of turnover in healthy tendons.

    The outcome measure will be assesed at time of surgery

  • Heavy water (D2O) enrichment in acutely ruptured Achilles tendons

    2H isotope enrichment in the biopsies from the ruptured part of the tendons and in the control biopsies proximal to the rupture.

    The outcome measure will be assesed at time of surgery

  • Fractional synthesis rate of protein at time of surgery in acutely ruptured Achilles tendons.

    The enrichment of the 15N marked proline tracer measured in the biopsies from the ruptured part of the tendons and in the control biopsies and compared to the enrichment of 15N marked proline in the blood. Based on that, the fractional synthesis rate of protein at the time of surgery is calculated.

    The outcome measure will be assesed at time of surgery

  • Presence of bacteria in acutely ruptured Achilles tendons.

    Presence of bacterial DNA in the biopsies from the ruptured part of the tendons and in the control biopsies proximal to the rupture detected by 16s rDNA PCR

    The outcome measure will be assesed at time of surgery

Study Arms (1)

Operatively treated patients with Achilles tendon rupture

Cohort of operatively treated patients with acute Achilles tendon rupture.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients diagnosed with acute Achilles tendon rupture, seen in the outpatient clinic at Copenhagen University Hospital, Hvidovre.

You may qualify if:

  • Age 18-70 years
  • Appointment in the Outpatients Department within 4 days after injury.
  • Total Acute Achilles tendon rupture
  • The patient must be able to speak and understand Danish.
  • The patient must be able to give informed consent.

You may not qualify if:

  • Rupture of the Achilles tendon either at the insertion on the calcaneus or at musculotendinous junction of the triceps surae.
  • Previous rupture of the same Achilles tendon
  • Undergone any surgery in the same region as the affected Achilles tendon.
  • In medical treatment of diabetes.
  • Present infection in the affected region.
  • Contra-indication for surgery: severe arthrosclerosis with no palpable pulse in the foot, broken skin in the Achilles region of the injured leg.
  • Inability to lie in prone position on the operating table.
  • Rheumatoid arthritis or any other inflammatory disorder of the joints.
  • Terminal illness or severe medical illness. ASA score higher than or equal to 3.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthopedic Surgery, Copenhagen University Hospital, Hvidovre

Hvidovre, 2650, Denmark

Location

Related Publications (1)

  • Cramer A, Hojfeldt G, Schjerling P, Agergaard J, van Hall G, Olsen J, Holmich P, Kjaer M, Barfod KW. Achilles Tendon Tissue Turnover Before and Immediately After an Acute Rupture. Am J Sports Med. 2023 Jul;51(9):2396-2403. doi: 10.1177/03635465231177890. Epub 2023 Jun 14.

Biospecimen

Retention: SAMPLES WITH DNA

Biopsies from acutely ruptured Achilles tendonds will be taken, Two biopsies from the ruptured part of the tendon and two biopsies from the healthy tissue of the same tendon proximal to the rupture, as a control.

Study Officials

  • Kristoffer W Barfod, MD

    Copenhagen University Hospital, Hvidovre

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 15, 2019

First Posted

April 30, 2019

Study Start

May 3, 2019

Primary Completion

April 1, 2021

Study Completion

April 1, 2021

Last Updated

July 29, 2021

Record last verified: 2021-07

Locations